Christopher Posner

Vorstandsvorsitzender bei CARA THERAPEUTICS, INC.

Vermögen: 45 559 $ am 30.06.2024

54 Jahre

Health Technology

Consumer Services

Retail Trade

Aktive Positionen von Christopher Posner

Unternehmen	Position	Beginn	Ende
CARA THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	06.08.2018	-
	Vorstandsvorsitzender	09.11.2021	-
	Präsident	09.11.2021	-
	Independent Dir/Board Member	06.08.2018	09.11.2021

Unternehmen	Position	Beginn	Ende
Leo Pharma, Inc. Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ.	Vorstandsvorsitzender	15.07.2017	01.10.2021
	Präsident	15.07.2017	01.10.2021
R-Pharm US LLC R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ.	Corporate Officer/Principal	01.01.2014	01.01.2017
ZEVRA THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	28.11.2022	-
ZEVRA THERAPEUTICS, INC.	Independent Dir/Board Member	28.11.2022	-

The Fuqua School of Business	Masters Business Admin
Villanova University	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
CARA THERAPEUTICS, INC.	Health Technology
ZEVRA THERAPEUTICS, INC.	Health Technology

Private Unternehmen	2
Leo Pharma, Inc. Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ.	Retail Trade
R-Pharm US LLC R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ.	Health Technology